GnRH agonists
Showing 1 - 25 of 1,033
Ovarian Response in Oocyte Donors Triggered With GnRH Agonists
Completed
- Poor Response to Ovulation Induction
-
Barcelona, SpainClinica EUGIN
Jul 20, 2022
Ovarian Endometrioma, Infertility, Female Trial (Laparoscopic enucleation of ovarian endometrioma., Prolonged pituitary
Not yet recruiting
- Ovarian Endometrioma
- Infertility, Female
- Laparoscopic enucleation of ovarian endometrioma.
- +2 more
- (no location specified)
Apr 28, 2021
Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)
Completed
- Angiogenesis
- Endometriosis
- Leuprolide Acetate
-
Patra, Peloponnese, Greece
- +1 more
Oct 27, 2023
Clomiphene Citrate asInhibitor of Ovulation inOocyte
Not yet recruiting
- Infertility, Female
- Infertility
-
Baton Rouge, LouisianaWomans Hospital
May 17, 2023
Endometriosis, Adenomyosis, Infertility, Female Trial in Suresnes (GnRH agonist)
Recruiting
- Endometriosis
- +2 more
- GnRH agonist
-
Suresnes, FranceHopital Foch
Aug 2, 2022
Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility Trial (ultrashort GnRHa, short GnRHa, long GnRHa)
Not yet recruiting
- Intracytoplasmic Sperm Injection
- +3 more
- ultrashort GnRHa
- +2 more
- (no location specified)
Oct 2, 2022
Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A
Not yet recruiting
- Metastatic Prostate Cancer
- +2 more
- Darolutamide
- +4 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 14, 2022
Luteal Phase Deficiency, Luteal Phase Support, Idiopathic Hypogonadotropic Hypogonadism Trial in Shanghai (Additional hCG
Recruiting
- Luteal Phase Deficiency
- +2 more
- Additional hCG injection
- estrogen and dydrogesterone
-
Shanghai, Shanghai, China
- +1 more
Oct 5, 2022
Ovarian Tissue Cryopreservation in Setting of Gender-affirming
Recruiting
- Gender Dysphoria
- Transgender
- Oophorectomy
- Infectious Disease Testing
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital
May 15, 2023
Infertility Trial (10000 IU hCG (Choriomon5000 IU; IBSA), Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring))
Not yet recruiting
- Infertility
- 10000 IU hCG (Choriomon5000 IU; IBSA)
- Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring)
- (no location specified)
May 27, 2022
Adenomyosis Trial in Modena (Enantone, Dienogest 2 MG (milligram), long GnRH agonist or flexible GnRH antagonist protocol.)
Recruiting
- Adenomyosis
- Enantone
- +2 more
-
Modena, ItalyAzienda Ospedaliero-Universitaria di Modena
Jul 6, 2023
Infertility, Endometriosis Trial in United States (Elagolix 200 MG, Placebo or SOC IVF)
Recruiting
- Infertility
- Endometriosis
- Elagolix 200 MG
- Placebo
-
Aurora, Colorado
- +4 more
Mar 15, 2022
Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)
Not yet recruiting
- Prostatic Adenocarcinoma
-
Seoul, Korea, Korea, Republic ofSamsung Medical Center
Aug 23, 2023
Ovarian Reserve in Premenopausal Breast Cancer
Terminated
- Premenopausal Breast Cancer
- Breast Cancer
-
Dublin, Dublin 18, Ireland
- +9 more
Jan 14, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Transgenderism Trial (gender affirming hormonal treatment in transgender men, gender affirming hormonal treatment in transgender
Not yet recruiting
- Transgenderism
- gender affirming hormonal treatment in transgender men
- gender affirming hormonal treatment in transgender women
- (no location specified)
Jul 22, 2022
Female Infertility Trial in Alexandria (gonadotropin releasing hormone-agonist, Progesterone)
Recruiting
- Female Infertility
- gonadotropin releasing hormone-agonist
- Progesterone
-
Alexandria, EgyptAlexandria University
Apr 5, 2022
Infertility Trial in Istanbul (Gonadotropin releasing hormone antagonist (Cetrotide), Medroxyprogesterone Acetate (Tarlusal),
Not yet recruiting
- Infertility
- Gonadotropin releasing hormone antagonist (Cetrotide)
- +2 more
-
Istanbul, TurkeyBezmialem Vakif University
Mar 13, 2023
Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for
Active, not recruiting
- Heavy Menstrual Bleeding
- Fibroid Uterus
- Groups 1 and 2 myomectomy and uterine artery embolization, respectively, are surgical/procedure
- Elagolix Oral Product
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Apr 29, 2022
Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)
Not yet recruiting
- Breast Cancer
- Ovarian Function Suppression + Aromatase Inhibitor
- Adjuvant Chemotherapy + Ovarian Function Suppression
- (no location specified)
May 19, 2023
Uterine Fibroid Trial in Cairo (Carbetocin)
Recruiting
- Uterine Fibroid
-
Cairo, EgyptFaculty of medicine, Cairo University
Aug 9, 2023
Testicular Tissue Cryopreservation in Setting of
Recruiting
- Gender Dysphoria
- Transgender
- Infectious Disease Testing
- Gonadal Tissue Removal
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital
Apr 13, 2023